Comparison of Short-term Sustained-release Opioid in Open Abdominal Urologic Surgeries

• Status: Recruiting
• Trial end date: 2024-04-30
• Target enrollment: 0
• Participant gender: All

Summary

The advantage of slow-release opioid allows for less fluctuation in drug (pain killer) levels in the blood and an extended period within the effective range for pain relief. The slow-release opioids have been preferred over the short-acting opioids because of the longer duration of action, which lessens the frequency and severity of end-of-dose pain.

Herein, the investigators propose the use of low dose slow-release opioid formulation offers better pain control in the first 48 hours post-operatively in open abdominal urologic surgeries.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alberta
• Treatments: Hydromorphone

Criteria

Inclusion Criteria:

• All adult patients undergoing open abdominal urologic surgeries

• ASA 1-3

Exclusion Criteria:

• Patient refusal

• history of chronic pain

• allergy to hydromorphone

• cannot swallow tablets